Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Peer Review reports

From: Methylmalonic acid, vitamin B12, and mortality risk in patients with preexisting coronary heart disease: a prospective cohort study

Original Submission
21 Sep 2023 Submitted Original manuscript
10 Oct 2023 Reviewed Reviewer Report
12 Oct 2023 Reviewed Reviewer Report
20 Oct 2023 Author responded Author comments - Shanjie Wang
20 Oct 2023 Author responded Author comments - Shanjie Wang
Resubmission - Version 2
20 Oct 2023 Submitted Manuscript version 2
28 Oct 2023 Reviewed Reviewer Report
1 Nov 2023 Author responded Author comments - Shanjie Wang
Resubmission - Version 3
1 Nov 2023 Submitted Manuscript version 3
Publishing
23 Nov 2023 Editorially accepted
29 Nov 2023 Article published 10.1186/s12937-023-00900-6

You can find further information about peer review here.

Back to article page